Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Merge Cardio™ has been named Best in KLAS for the cardiology software category within the “2014 Best in KLAS: Software & Services” report. In addition, Merge Hemo™ has been named the KLAS Category Leader in Cardiology Hemodynamics. This marks the second and fourth consecutive wins for Merge Cardio and Merge Hemo, respectively.
“We’re excited Merge Cardio has maintained its number one status with KLAS and Merge Hemo continues to be the KLAS Category Leader. Receiving the top two cardiology honors is a testament to our continued collaboration with clients to improve existing solutions and develop technology to prepare them for the future,” said Justin Dearborn, CEO of Merge Healthcare. “As healthcare organizations strive for interoperability, solutions to manage data in cardiology will be evermore critical to achieving a streamlined approach across the care continuum. At Merge, we value working closely with clients to achieve this goal.”
Merge Cardio, implemented in over 200 organizations, gives providers the ability to access and manage patients’ digital integrated cardiovascular record from a centralized, web-based system. Merge Hemo automates cath lab processes into an electronic health record to enable efficient workflow, and is currently running in over 500 cardiac cath labs in some of the country’s largest health systems. Together, these top cardiology solutions provide a seamless solution for advanced reporting and enhanced workflow.
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. KLAS was founded in 1996, and their staff and advisory board members average 25 years of healthcare information technology experience. For more information, to go www.KLASresearch.com, email marketing@KLASresearch.com, or call 1800-920-4109 to speak with a KLAS representative. Follow KLAS on Twitter at @KLASresearch.
Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge’s enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs, improve efficiencies and enhance the quality of healthcare worldwide. For more information, visit merge.com and follow us @MergeHealthcare.
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this press release may include forward-looking statements, which could involve a number of risks and uncertainties including the outcome of the internal investigation and the remedial actions involving the former employee. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.